Means (SDs) across assessments
Group . | Skype (n = 46) . | Clinic (n = 44) . | ||||
---|---|---|---|---|---|---|
Before intervention . | After intervention . | Follow-up . | Before intervention . | After intervention . | Follow-up . | |
HbA1c | ||||||
% | 11.15 (1.73) | 10.40 (1.66) | 10.61 (1.83) | 11.10 (2.14) | 10.45 (2.05) | 10.31 (1.95) |
mmol/mol | 98.4 (15.27) | 90.2 (14.40) | 92.5 (15.95) | 97.8 (18.86) | 90.7 (19.53) | 89.2 (16.87) |
P-DSMP | 48.12 (13.55) | 52.84 (13.49) | 50.09 (12.91) | 46.01 (12.05) | 53.61 (11.83) | 51.83 (11.88) |
Y-DSMP | 52.64 (11.59) | 56.10 (13.30) | 55.55 (12.81) | 51.81 (11.53) | 58.07 (8.25) | 57.66 (9.50) |
Group . | Skype (n = 46) . | Clinic (n = 44) . | ||||
---|---|---|---|---|---|---|
Before intervention . | After intervention . | Follow-up . | Before intervention . | After intervention . | Follow-up . | |
HbA1c | ||||||
% | 11.15 (1.73) | 10.40 (1.66) | 10.61 (1.83) | 11.10 (2.14) | 10.45 (2.05) | 10.31 (1.95) |
mmol/mol | 98.4 (15.27) | 90.2 (14.40) | 92.5 (15.95) | 97.8 (18.86) | 90.7 (19.53) | 89.2 (16.87) |
P-DSMP | 48.12 (13.55) | 52.84 (13.49) | 50.09 (12.91) | 46.01 (12.05) | 53.61 (11.83) | 51.83 (11.88) |
Y-DSMP | 52.64 (11.59) | 56.10 (13.30) | 55.55 (12.81) | 51.81 (11.53) | 58.07 (8.25) | 57.66 (9.50) |